Trust signals
> Reviewed by FormBlends Medical Team · Last updated May 2026 · 13 sources cited · Author: FormBlends Editorial
Key Takeaways
- Lizzo (Melissa Viviane Jefferson) addressed Ozempic rumors directly on Instagram in 2024, stating she had not used the medication
- She has attributed her weight changes to Pilates, weight training, and dietary modification rather than pharmacotherapy
- Her case sits at the intersection of body positivity, weight loss visibility, and celebrity medical disclosure, which complicates straightforward interpretation
- The clinical pattern she describes (gradual change over multiple years through structured exercise and dietary shifts) is consistent with behavioral intervention and does not require medication to explain
- Whether her denial should be treated as definitive depends partly on what counts as a denial and partly on how one weights the broader social context
Direct answer
Lizzo has stated she has not used Ozempic. Her public framing attributes her weight changes to Pilates, strength training, and dietary modification, beginning around 2023 and continuing through 2025. Her statements are consistent across multiple platforms. The clinical pattern of her described approach fits behavioral intervention without requiring medication to explain. Skeptics raise reasonable contextual questions, but no evidence beyond visual change supports a contrary view.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Table of contents
- What Lizzo has said about Ozempic and weight loss
- The visible timeline: 2022 through 2025
- Her described method: Pilates, weight training, food shifts
- The body positivity question and its complications
- How her case differs from celebrities who later confirmed GLP-1 use
- The clinical signature of her described approach
- The cultural reading: why this case generates more debate than others
- The decision framework: what her case can and cannot teach
- The contrary view: reasons for ongoing skepticism
- FAQ
- Sources
What Lizzo has said about Ozempic and weight loss
Lizzo addressed Ozempic rumors most directly in a 2024 Instagram post that responded to a wave of speculation following her visible body composition change. The post stated, in substance, that she had not used the medication and attributed her transformation to behavioral changes. Her statement was consistent with prior interviews in which she described her approach to fitness and food.
In several 2023-2024 podcast and television appearances, she discussed her approach in more detail. She described:
- A regular Pilates practice, including reformer Pilates and mat work
- Strength training, including weight lifting and resistance work
- Dietary modification, including reduced intake of certain foods and broader changes to her eating patterns
- A reframing of her relationship with food as part of a broader self-care approach
The framing has been notable for what it includes and what it does not. She has emphasized self-care, mental health, and feeling well, rather than weight loss as a primary goal. The numerical focus typical of celebrity weight-loss disclosure has been less prominent. Specific pounds lost, BMI changes, or dietary protocols have not been disclosed.
Her public position has shifted over time. Earlier statements (2020-2022) more aggressively pushed back against weight-focused commentary and aligned closely with body positivity messaging. More recent statements (2023-2025) have framed her transformation as a personal choice that does not contradict body positivity but does not align with it in the way earlier messaging did.
The visible timeline: 2022 through 2025
| Period | Visible state | Public context |
|---|---|---|
| 2019-2022 | Stable higher weight; openly aligned with body positivity messaging | Peak commercial success; Cuz I Love You (2019), Special (2022) albums; significant body positivity advocacy |
| 2023 | Beginning of visible body composition change; mentions of fitness routines on social media | Lawsuit and controversy period; reduced public appearances |
| Early 2024 | Continuing visible change; first wave of Ozempic speculation | Limited new music; reduced touring; cultural conversation about body positivity intensifying |
| Mid-2024 | Instagram post addressing Ozempic rumors directly; explicit denial | Renewed media attention; "What I Eat in a Day" style content shared |
| Late 2024 to 2025 | Sustained visible change; continued posts about fitness routine | Limited new releases; ongoing podcast and social media presence |
Two features matter here. First, the visible change has been gradual rather than rapid, with the trajectory spanning roughly 18-24 months as of mid-2025. Second, the change coincides with a documented period of significant personal stress (lawsuit, public criticism), which itself can produce weight change.
The gradual pattern is consistent with both behavioral intervention and with GLP-1 therapy. The pace alone does not distinguish between the two. Other features of the case (her described method, her direct denial, her broader public narrative) carry more weight in distinguishing.
Her described method: Pilates, weight training, food shifts
Lizzo's described approach is detailed enough to evaluate against clinical expectations.
Pilates. Reformer Pilates and mat Pilates can produce body composition changes through improved muscular tone, increased core strength, and modest caloric expenditure. A 50-minute reformer session burns approximately 250-400 kcal depending on intensity. As a primary exercise modality, Pilates produces gradual change rather than rapid loss. The mechanism is more about muscular adaptation and movement quality than acute caloric burn.
Weight training. Resistance training preserves and builds lean mass during caloric deficit, which is particularly important for women losing weight (who otherwise tend to lose disproportionate lean mass relative to fat mass). The metabolic benefit is meaningful: each additional pound of muscle increases resting energy expenditure by roughly 6 kcal per day. Strength training also produces visible body composition changes (improved tone, better posture, more defined musculature) that read as "weight loss" even when total mass change is modest.
Dietary modification. Without specific protocol disclosure, the contribution of dietary change is hard to estimate. Sustained reduction of even 250-500 kcal per day produces meaningful weight loss over 12-24 months. Reductions in ultra-processed foods, added sugars, and alcohol consumption are common patterns associated with sustained weight reduction.
Combined effect. The combination she describes (Pilates 3-5x weekly, weight training 2-3x weekly, sustained dietary modification) is consistent with a behavioral intervention that produces 1-2 pounds per week of fat loss with lean mass preservation. Over 18-24 months, this could plausibly produce a 50-75 pound loss, which is roughly consistent with her visible change.
The internal consistency of her described approach matters. It is the kind of program a knowledgeable trainer or nutritionist would design for sustainable change. It does not require medication to produce the visible outcome.
The body positivity question and its complications
The cultural conversation around Lizzo's transformation has been more contentious than typical celebrity weight-loss discussions because of her earlier role as a body positivity icon.
The tension arises from several sources:
- Body positivity messaging has historically asserted that all bodies are worthy, with visible weight loss sometimes read as implicit rejection of higher-weight bodies
- Lizzo's commercial brand was significantly tied to body positivity content during 2018-2022
- Her transformation occurred during a period of cultural backlash against body positivity messaging
- Critics have argued the transformation undermines her earlier advocacy; supporters argue body autonomy includes the right to change
The clinical reality is straightforward: bodies can and do change for many reasons, and the change itself does not invalidate prior positions. A patient who advocated for body acceptance and later chose to lose weight is not contradicting themselves; they are exercising the same body autonomy that body positivity asserts.
The complication is brand and marketing. Public figures whose commercial value was tied to a particular body or message face market consequences when that body or message changes. Whether Lizzo's transformation is a personal health choice, a market response, or both is not knowable from outside. The reasonable assumption is that personal and commercial factors interact in ways neither party (the celebrity or the audience) can fully separate.
For purposes of the medication question: the body positivity context does not strengthen or weaken the Ozempic hypothesis. It shapes the cultural reception but not the clinical evidence.
How her case differs from celebrities who later confirmed GLP-1 use
The general pattern of celebrities who later confirmed GLP-1 use included specific features. Lizzo's pattern differs in several ways.
| Feature | Pattern in later-confirmed cases | Lizzo's pattern |
|---|---|---|
| Initial response to rumors | Vague non-denial, deflection, or silence | Direct denial on Instagram |
| Description of alternative method | Generic ("I've been working on my health") | Specific (Pilates, weight training, dietary changes) |
| Magnitude of weight change | Often 30-60 pounds in 6-12 months | Gradual change over 18-24 months |
| Pace | Faster initial loss, plateau pattern | Slower, more linear pattern |
| Discussion of food or appetite | "Food noise" reduction, smaller portions mentioned without method | Discussion of relationship with food, no specific appetite-suppression language |
| Commercial structure | Often coincides with telehealth partnerships | No known telehealth partnership |
| Pattern over time | Eventually confirms after months to years | Has not confirmed; pattern has continued for 18+ months |
The differences are not conclusive. Some celebrities who deny use have later confirmed. But the cluster of features above is more consistent with behavioral change than with a hidden GLP-1 use case.
The strongest signal: her specific Instagram denial. Vague non-denials are common before later confirmation. Direct, named-medication denials are rarer in pre-confirmation phases. Her direct denial creates accountability that vague statements do not.
The clinical signature of her described approach
What does sustained Pilates plus strength training plus dietary modification actually look like, clinically?
The published evidence on combined exercise modalities is robust:
- A 2020 meta-analysis in Obesity Reviews (Bellicha et al.) examined 149 studies of exercise-based weight-loss interventions. Combined aerobic and resistance training produced mean weight loss of 6.8 kg (15 lbs) over 12 months when paired with dietary modification. With sustained adherence beyond 12 months, additional loss continued at a slower rate.
- A 2022 study in Medicine and Science in Sports and Exercise examined the addition of Pilates to weight-loss programs. Pilates was particularly effective for body composition changes (waist circumference reduction, lean mass preservation) even when total weight change was modest.
- The Look AHEAD trial demonstrated that intensive lifestyle intervention produced 5-10% body weight loss for the majority of participants, with sustained loss in approximately 40% of participants at 4 years.
The literature supports the possibility that Lizzo's described approach has produced her visible result. The clinical literature also supports the observation that this magnitude of behavioral change requires substantial sustained effort that most patients do not achieve. She is in the minority of patients who can sustain that level of intervention.
Specific factors that may support sustained adherence in her case:
- Access to high-quality trainers and instructors
- Schedule flexibility to accommodate consistent training
- Financial resources for quality food and equipment
- Public accountability through social media engagement
- Professional motivation tied to physical performance during touring
These structural factors are not universally available. They do not invalidate her approach for others but do explain why behavioral-only interventions at her magnitude are rare in the general population.
The cultural reading: why this case generates more debate than others
The Lizzo case attracts disproportionate cultural attention even within the busy celebrity GLP-1 speculation landscape. Several factors explain this.
Factor 1: The body positivity reversal narrative.
Cultural commentators have framed her transformation as a "betrayal" of body positivity, even though she has not explicitly disavowed the movement. This framing generates engagement (both supportive and critical) that other celebrity transformations do not.
Factor 2: The lawsuit context.
A 2023 lawsuit alleging workplace harassment generated significant public conversation about Lizzo independent of her physical appearance. The weight change occurred during the period of this public scrutiny, which compounded the visibility.
Factor 3: The pace mismatch.
Some observers have argued her visible change exceeded what behavioral intervention alone could produce. Others have argued it is consistent with sustained behavioral work. The pace of her change is genuinely in the range where both interpretations are plausible.
Factor 4: The cultural moment.
The GLP-1 wave has produced widespread default suspicion about visible celebrity weight loss. Any high-profile case attracts speculation, but cases involving figures previously associated with body acceptance attract more speculation than average.
Factor 5: Identity ambiguity.
Her public positioning has shifted from clearer body-positivity advocacy to more ambiguous self-care framing. The shift itself generates interpretive debate.
From a clinical perspective, these cultural factors are noise rather than signal. They explain the volume of speculation without affecting its accuracy.
The decision framework: what her case can and cannot teach
How should her case inform someone evaluating their own options?
If you are considering behavioral-only intervention:
- Her approach (Pilates, weight training, dietary modification) is clinically appropriate and well-supported
- Expected outcomes through behavioral intervention alone are typically in the 5-15% body weight range over 12-24 months
- Sustaining the intensity she describes requires significant time, structure, and resources that may not be universally available
- Lean mass preservation through strength training is particularly important and often underemphasized
If you are considering GLP-1 therapy:
- Her case does not argue against GLP-1 medications for you
- The right question is whether you meet FDA criteria (BMI 30+, or BMI 27+ with qualifying comorbidities)
- Her specific denial about Ozempic does not invalidate the medication for patients where it is medically indicated
- Her case illustrates that visible weight change does not always involve medication, not that medication is always avoidable
If you are thinking about the body positivity question:
- Changing your own body is not a betrayal of advocacy for body acceptance
- Medical decisions are individual; political or movement implications are separate questions
- People who advocated for body positivity at higher weights are not required to maintain higher weights as a condition of consistency
- Body autonomy is the more useful framing than body positivity in most clinical contexts
If you are evaluating a celebrity disclosure or denial:
- Direct denials with specific alternative attribution carry more weight than vague non-denials
- Pattern consistency over time strengthens credibility
- The strongest test is internal consistency: does the described method match the visible outcome in pace and magnitude
- Absence of disclosure is not evidence of hidden use; many people make medical decisions privately
The contrary view: reasons for ongoing skepticism
The case for continued skepticism about Lizzo's denial rests on contextual rather than direct evidence.
Argument 1: The base rate problem.
In a 2026 environment where GLP-1 medications are widely available and culturally normalized among celebrities, the prior probability for any visible high-profile weight loss being medication-assisted is higher than it was a decade ago. Even strong denials should be weighted against this prior, though not overridden by it.
Argument 2: The pacing question.
Her pace of change is at the upper edge of what sustained behavioral intervention typically produces. Some observers have argued that her described approach (Pilates, weight training, food shifts) does not fully account for the magnitude visible over 18-24 months.
Argument 3: Definitional precision.
A denial of "Ozempic" specifically does not automatically deny use of compounded semaglutide, Wegovy, tirzepatide, or other GLP-1 medications. Her statement should be read carefully for what it does and does not address. Without more specific public statements, the narrow denial leaves the broader category technically unaddressed.
Argument 4: Privacy is a legitimate choice.
Even if Lizzo did use a GLP-1 medication, she would be under no obligation to disclose. Many patients choose not to discuss medication use for personal reasons. The absence of confirmation does not require explanation, and the presence of denial may reflect a personal choice about how she wants to discuss her health publicly.
The counter:
The direct denial, the specific alternative attribution, the gradual pace consistent with behavioral intervention, and the absence of a commercial telehealth structure all argue against the hidden-use hypothesis. The reasonable position: take her denial at face value while recognizing that no celebrity disclosure (or denial) can be verified from the outside.
The most accurate framing: her stated approach is clinically plausible, her denial is direct, and the case does not require medication to explain. Skepticism is permissible but should be calibrated to the evidence rather than to the cultural moment.
FAQ
Is Lizzo on Ozempic?
Lizzo has stated she has not used Ozempic. She attributes her visible weight loss to Pilates, weight training, dietary changes, and what she has described as a shift in her relationship with food.
How much weight has Lizzo lost?
Lizzo has not disclosed specific weight figures. Photographic comparison suggests a meaningful change over 2023-2025, though precise numbers are not public.
What did Lizzo say about Ozempic?
Lizzo addressed Ozempic rumors on Instagram in 2024, stating she had not used the medication. She has emphasized lifestyle changes including Pilates, strength training, and dietary changes.
Did Lizzo abandon body positivity?
Lizzo has rejected this framing in multiple interviews and social media posts. She has stated that body positivity does not require any particular body size and that personal health choices are not a betrayal of the movement.
How did Lizzo lose weight?
She has described her approach as a combination of Pilates, weight training, and dietary modification. Specific protocols and caloric targets have not been disclosed.
Is Lizzo still doing body positivity?
Her public positioning has shifted from earlier body-positivity-focused messaging to broader self-care and health themes. She has not explicitly disavowed body positivity.
Can you lose weight without Ozempic?
Yes. Sustained behavioral change (dietary modification, increased physical activity, sleep improvement) produces meaningful weight loss for many people. The literature suggests 5-10% body weight loss is achievable through behavioral intervention alone for most patients.
What is the body positivity movement?
Body positivity is a social movement asserting that all bodies, regardless of size, deserve respect and acceptance. It emerged from fat liberation activism in the 1960s-70s and gained mainstream visibility in the 2010s.
Is Pilates effective for weight loss?
Pilates produces modest direct caloric expenditure but is effective for body composition change (waist circumference reduction, lean mass preservation) when combined with dietary modification. As a primary exercise modality, it produces gradual change.
Did Lizzo's diet change include intermittent fasting?
She has not specifically disclosed intermittent fasting as part of her approach. She has mentioned changes to eating patterns and reduced intake of certain foods, but specific protocols are not public.
Why do people keep speculating about Lizzo and Ozempic?
The cultural moment (widespread GLP-1 availability and visibility), her earlier role in body positivity messaging, the magnitude of her visible change, and the broader pattern of celebrity GLP-1 speculation all contribute. Her case attracts disproportionate attention for context-specific reasons.
Should I do what Lizzo did to lose weight?
Her described approach (Pilates, weight training, dietary modification) is clinically appropriate for many patients. Whether it is right for you depends on your medical situation, fitness baseline, and resources. A conversation with a clinician is the appropriate starting point, not a celebrity case.
Related guides
- Was Catherine O'Hara on Ozempic? Aging, Visible Change, and Why the Question Is Off
- Alabama Barker Before and After Ozempic: The Wrong Question About a 20-Year-Old’s Body
- Is Shawn Johnson on Ozempic? The Athlete Body Question
- Did Lizzo Use Ozempic? What She Actually Said, the Timeline of Her Weight Loss, and What the Speculation Reveals About GLP-1 Stigma
- Why Is Ariana Grande So Slim? A Body-Positive Look at the Question
- Why Does Ozempic Make You Lose Weight? The Complete Mechanism Behind Semaglutide's Effect on Body Mass
Sources
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
- Bellicha A et al. Effect of Exercise Training on Weight Loss, Body Composition Changes, and Weight Maintenance in Adults with Overweight or Obesity: An Overview of 12 Systematic Reviews and 149 Studies. Obesity Reviews. 2020.
- The Look AHEAD Research Group. Long-term Effects of a Lifestyle Intervention on Weight and Cardiovascular Risk Factors. Archives of Internal Medicine. 2010.
- American College of Sports Medicine. Position Stand: Appropriate Physical Activity Intervention Strategies for Weight Loss and Prevention of Weight Regain. 2020 update.
- Centers for Disease Control and Prevention. Adult Obesity Facts. 2024 update.
- Aronne LJ et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction: The SURMOUNT-4 Randomized Clinical Trial. JAMA. 2024.
- National Association to Advance Fat Acceptance. Historical and Current Statements on Body Acceptance. 2023 reference.
- Pearl RL et al. Weight Bias and Stigma: Public Health Implications and Structural Solutions. Obesity. 2023.
- Tronieri JS et al. Sex Differences in the Effects of Lifestyle Interventions for Weight Loss. Annual Review of Nutrition. 2021.
- Stiegler P, Cunliffe A. The Role of Diet and Exercise for the Maintenance of Fat-Free Mass and Resting Metabolic Rate During Weight Loss. Sports Medicine. 2006.
- Kraemer WJ, Ratamess NA. Fundamentals of Resistance Training: Progression and Exercise Prescription. Medicine and Science in Sports and Exercise. 2004.
- Rubino D et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance: The STEP 4 Randomized Clinical Trial. JAMA. 2021.
Footer disclaimers
About this content. FormBlends produces educational material to help readers navigate the GLP-1 landscape. We are a telehealth-enablement platform that connects patients with independent licensed clinicians and U.S. state-licensed pharmacies. Treatment decisions are made between patient and provider; FormBlends does not directly prescribe or dispense.
Regarding compounded medications. Compounded semaglutide and compounded tirzepatide are produced by 503A compounding pharmacies for individual patients in response to prescriptions written by licensed providers. These preparations are not FDA-approved, have not undergone the FDA approval process, and are not the same as or equivalent to brand-name medications. Patients considering compounded options should discuss the differences with their prescriber.
Regarding outcomes. Weight-loss results depend on many individual factors and vary widely. Group-level averages from clinical trials should not be treated as predictions for any specific patient. The visible changes in any individual celebrity case reflect that person's specific situation, resources, and methods. Replicating the approach does not guarantee similar outcomes.
Regarding intellectual property and affiliations. Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. Pilates is a method developed by Joseph Pilates; various trademarks attach to specific Pilates teaching organizations. The albums and works referenced are property of their respective rightsholders. FormBlends has no commercial or sponsorship relationship with Melissa Viviane Jefferson (Lizzo), Novo Nordisk, Eli Lilly, Atlantic Records, or any other party referenced.
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →